| Authors: |
Singh A; EpLink - The Epilepsy Research Program of the Ontario Brain Institute, Toronto, Ontario, Canada; Department of Pharmacology & Toxicology, University of Toronto, Toronto, Ontario, Canada. Electronic address: amaya.singh@utoronto.ca., Woelfle R; EpLink - The Epilepsy Research Program of the Ontario Brain Institute, Toronto, Ontario, Canada; Department of Pharmacology & Toxicology, University of Toronto, Toronto, Ontario, Canada., Chepesiuk R; Ontario Brain Institute, Toronto, Ontario, Canada., Southward C; Ontario Brain Institute, Toronto, Ontario, Canada., Antflick J; Ontario Brain Institute, Toronto, Ontario, Canada., Cowan K; The James Lind Alliance, The Wessex Institute, University of Southampton, Southampton, United Kingdom., Hum K; EpLink - The Epilepsy Research Program of the Ontario Brain Institute, Toronto, Ontario, Canada; Department of Pharmacology & Toxicology, University of Toronto, Toronto, Ontario, Canada., Ng M; Section of Neurology, Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada., Burneo JG; Epilepsy Program, Department of Clinical Neurological Sciences, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada; Neuroepidemiology Unit, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada., Suller Marti A; Epilepsy Program, Department of Clinical Neurological Sciences, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada; Paediatrics Department, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada; Neurosciences Program, Western University, London, Ontario, Canada. |
